News Sentiment

IVVD sentiment intelligence

Invivyd Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.78 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-12.4% over one week, +1.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Here's Why We're Not Too Worried About Invivyd's (NASDAQ:IVVD) Cash Burn Situation

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -12.4% Price reacting lower
Trend fit Trend inactive 1.7% over four weeks
Fair value -51.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 33
Negative 12

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
Stock Titan 8
TradingView 6
simplywall.st 5
MT Newswires 3
www.marketscreener.com 3
The Globe and Mail 2
ad-hoc-news.de 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 18
Analyst action 6
Regulatory and legal 2
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 57
Simply Wall Street Direct company coverage

Here's Why We're Not Too Worried About Invivyd's (NASDAQ:IVVD) Cash Burn Situation

Invivyd (NASDAQ:IVVD) has a cash runway of about 2.3 years and analysts predict the company will reach cashflow breakeven in 3 years. While its cash burn of US$79m represents 32% of its market capitalization, which could lead to dilution if more capital is needed, its 52% revenue

Tone
Positive 62/100
Event
Balance sheet
Published
10 Jul 2026 18:11
Source
Simply Wall Street
The Globe and Mail Direct company coverage

Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)

Analysts have provided varied ratings for three healthcare companies. Stifel Nicolaus maintained a Buy rating for Cipher Pharmaceuticals with a C$22.00 price target, while Cantor Fitzgerald maintained a Buy rating for Invivyd with a $10.00 price target. Morgan Stanley, however, i

Tone
Positive 75/100
Event
Analyst action
Published
10 Jul 2026 13:10
Source
The Globe and Mail
Investing.com Direct company coverage

H.C. Wainwright reiterates Invivyd stock rating on regulatory path

H.C. Wainwright has reiterated a Buy rating and a $10.00 price target for Invivyd Inc. (NASDAQ:IVVD) following recent regulatory developments regarding its COVID-19 antibody treatment, PEMGARDA. The FDA issued a Notice of Termination for PEMGARDA's Emergency Use Authorization, ef

Tone
Positive 64/100
Event
Analyst action
Published
08 Jul 2026 17:09
Source
Investing.com
Investing.com Nigeria Direct company coverage

H.C. Wainwright reiterates Invivyd stock rating on regulatory path By Investing.com

H.C. Wainwright has reiterated a Buy rating and a $10.00 price target for Invivyd Inc. (NASDAQ:IVVD) following recent regulatory developments regarding its COVID-19 antibody treatment, PEMGARDA. The FDA issued a Notice of Termination for PEMGARDA's Emergency Use Authorization, ef

Tone
Positive 63/100
Event
Analyst action
Published
08 Jul 2026 11:40
Source
Investing.com Nigeria
Moomoo Direct company coverage

Invivyd, Inc. Announces FDA Notice of Termination for PEMGARDA EUA Following HHS COVID-19 Emergency Declaration Wind-Down

Invivyd, Inc. announced that the FDA issued a notice of termination for the Emergency Use Authorization (EUA) of PEMGARDA (pemivibart) due to the wind-down of the COVID-19 Public Health Emergency Declaration by the U.S. Department of Health and Human Services. The termination bec

Tone
Negative 20/100
Event
Market update
Published
08 Jul 2026 06:43
Source
Moomoo
TradingView Direct company coverage

Invivyd receives 12-month notice of EUA termination for PEMGARDA, plans FDA dialogue

Invivyd has received a 12-month notice from the FDA regarding the termination of the Emergency Use Authorization (EUA) for its drug PEMGARDA, effective June 29, 2027, following a similar declaration from HHS concerning COVID-19 EUAs. The company is actively discussing with the FD

Tone
Negative 29/100
Event
Market update
Published
06 Jul 2026 16:40
Source
TradingView
Stocktwits Direct company coverage

IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730%

Invivyd Inc. (IVVD) stock dropped over 19% after reporting first-quarter revenue of $13.7 million, significantly missing analyst estimates of $18 million. Despite this, H.C. Wainwright & Co. reiterated a 'Buy' rating and a $10 price target, suggesting a potential upside of over 7

Tone
Neutral 50/100
Event
Analyst action
Published
06 Jul 2026 16:14
Source
Stocktwits
grafa.com Direct company coverage

Invivyd receives FDA termination notice for PEMGARDA EUA

Invivyd (NASDAQ:IVVD) announced that the FDA's Emergency Use Authorization for its COVID-19 antibody treatment, PEMGARDA, will terminate on June 29, 2027. This decision aligns with the Department of Health and Human Services' conclusion of the national COVID-19 emergency declarat

Tone
Negative 40/100
Event
Market update
Published
06 Jul 2026 12:21
Source
grafa.com
Stock Titan Direct company coverage

Invivyd (NASDAQ: IVVD) faces 2027 end of PEMGARDA COVID EUA

Invivyd (NASDAQ: IVVD) announced that the FDA has issued a Notice of Termination for the Emergency Use Authorization (EUA) of its COVID-19 monoclonal antibody, PEMGARDA, effective June 29, 2027. This follows the HHS's decision to end the COVID-19 EUA declaration. PEMGARDA will re

Tone
Negative 36/100
Event
Market update
Published
06 Jul 2026 11:11
Source
Stock Titan
Stock Titan Direct company coverage

PEMGARDA faces 2027 EUA end as Invivyd talks next steps with FDA

Invivyd (Nasdaq: IVVD) has received advanced notice from the FDA that the Emergency Use Authorization (EUA) for its COVID-19 preventative treatment, PEMGARDA, will terminate on June 29, 2027, following the planned end of the HHS COVID-19 EUA declaration. Despite this, Invivyd is

Tone
Negative 31/100
Event
Market update
Published
06 Jul 2026 11:11
Source
Stock Titan
Finviz Direct company coverage

IVVD - Invivyd Inc Short Interest

This article provides a detailed financial overview and short interest data for Invivyd Inc (IVVD). It includes key metrics such as market capitalization, sales, earnings per share, and various performance indicators. The data highlights the company's short interest, institutiona

Tone
Negative 41/100
Event
Earnings
Published
05 Jul 2026 19:40
Source
Finviz
TradingView Direct company coverage

Price to sales forward of Invivyd, Inc. – NASDAQ:IVVD

This article provides the "Price to sales forward" metric for Invivyd, Inc. (NASDAQ: IVVD). It appears to be a financial data snippet from TradingView, focusing on a single financial ratio for the company.

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 16:11
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Invivyd, Inc. – NASDAQ:IVVD

This article provides financial information for Invivyd, Inc. (NASDAQ: IVVD), specifically focusing on its forward price-to-earnings ratio. It directs users to TradingView for market data, technical analysis, and other financial tools related to the company. The content appears t

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 08:39
Source
TradingView
Finviz Direct company coverage

IVVD - Invivyd Inc Forecast, Target Price

This article provides a detailed financial overview and forecast for Invivyd Inc. (IVVD), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance indicators, insider/institutional ownership, short interes

Tone
Neutral 50/100
Event
Guidance
Published
04 Jul 2026 12:09
Source
Finviz
TradingView Direct company coverage

Enterprise value to EBITDA forward of Invivyd, Inc. – NASDAQ:IVVD

This article briefly presents the "Enterprise value to EBITDA forward" metric for Invivyd, Inc. (NASDAQ:IVVD) within the TradingView platform. It shows the company's stock market information and indicates that the market is closed with no trades. The article is a stub, likely par

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 08:10
Source
TradingView
The Globe and Mail Direct company coverage

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Invivyd, Inc. announced that it granted 14 newly hired non-executive employees options to purchase 493,000 shares of its common stock as an inducement to employment. These options were issued on July 1, 2026, under Nasdaq Listing Rule 5635(c)(4) and the company's 2026 Inducement

Tone
Positive 62/100
Event
Market update
Published
03 Jul 2026 03:10
Source
The Globe and Mail
Stock Titan Direct company coverage

Invivyd gives 14 new hires stock options worth 493,000 shares

Invivyd (Nasdaq: IVVD) announced it granted 493,000 stock options to 14 newly hired non-executive employees as an inducement for employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $0.8544 per share, matching the closing price on t

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 11:12
Source
Stock Titan
www.marketscreener.com Direct company coverage

Invivyd, Inc.(NasdaqGM: IVVD) added to Russell Microcap Value Benchmark Index

Invivyd, Inc. (NasdaqGM: IVVD) has been added to the Russell Microcap Value Benchmark Index. This news follows a series of recent index inclusions for the biopharmaceutical company, which also saw its addition to the Russell 2000 Index and Russell 2000 Value Benchmark Index on th

Tone
Positive 70/100
Event
Market update
Published
29 Jun 2026 16:15
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Invivyd, Inc.(NasdaqGM: IVVD) added to Russell Microcap Index

Invivyd, Inc. (NasdaqGM: IVVD) has been added to the Russell Microcap Index. This follows a recent period of news for the biopharmaceutical company, including its completion of enrollment in a Phase 3 clinical trial for a COVID-19 antibody. The company specializes in developing a

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 06:09
Source
www.marketscreener.com
TradingView Direct company coverage

Invivyd, Inc. Actuals & Estimates (NASDAQ:IVVD)

This article provides an overview of Invivyd, Inc. (NASDAQ: IVVD) stock, including its current price, historical performance, analyst forecasts, and key financial metrics. It details earnings, revenue, market capitalization, and volatility, and confirms that the company does not

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:39
Source
TradingView
TMX Newsfile Direct company coverage

Invivyd Shareholder Notice

Faruqi & Faruqi, LLP is investigating potential securities claims against Invivyd, Inc. (NASDAQ: IVVD) and encouraging investors who lost over $100,000 to seek lead plaintiff status in a federal securities class action. The lawsuit alleges that Invivyd made misleading statements

Tone
Negative 9/100
Event
Regulatory and legal
Published
25 Jun 2026 02:10
Source
TMX Newsfile
TradingKey Direct company coverage

Invivyd Inc (IVVD) Financial Health: Profitability & Balance Sheet Analysis

Invivyd Inc (IVVD) has a robust financial status with a current financial score of 8.37, ranking 63 out of 157 in the Pharmaceuticals industry. The company reported a significant year-over-year revenue increase of 21.59% to 13.74M and a net profit increase of 154.16%. Its strong

Tone
Positive 72/100
Event
Earnings
Published
23 Jun 2026 08:10
Source
TradingKey